Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML | PFIZER PRIVATE LIMITED | ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML | Dec 31, 2024 | SIN17155P |
| ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML | PFIZER PRIVATE LIMITED | ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML | Dec 31, 2024 | SIN17156P |
| CONJUPRI TABLETS 5MG | LOTUS INTERNATIONAL PTE. LTD. | CONJUPRI TABLETS 5MG | Dec 26, 2024 | SIN17153P |
| CONJUPRI TABLETS 2.5MG | LOTUS INTERNATIONAL PTE. LTD. | CONJUPRI TABLETS 2.5MG | Dec 26, 2024 | SIN17154P |
| VOYDEYA FILM-COATED TABLET 100 MG + 100 MG | ASTRAZENECA SINGAPORE PTE LTD | VOYDEYA FILM-COATED TABLET 100 MG + 100 MG | Dec 26, 2024 | SIN17151P |
| VOYDEYA FILM-COATED TABLET 100 MG + 50 MG | ASTRAZENECA SINGAPORE PTE LTD | VOYDEYA FILM-COATED TABLET 100 MG + 50 MG | Dec 26, 2024 | SIN17152P |
| TAVNEOS HARD CAPSULE 10MG | AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD. | TAVNEOS HARD CAPSULE 10MG | Dec 24, 2024 | SIN17150P |
| CYTARINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/ML | FRESENIUS KABI (SINGAPORE) PTE LTD | CYTARINE KABI SOLUTION FOR INJECTION OR INFUSION 100MG/ML | Dec 18, 2024 | SIN17149P |
| NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV | PE PHARMA PTE. LTD. | NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV | Dec 16, 2024 | SIN17148P |
| Plerixafor-AFT solution for injection 24 mg/1.2 mL | APEX PHARMA MARKETING PTE. LTD. | Plerixafor-AFT solution for injection 24 mg/1.2 mL | Dec 12, 2024 | SIN17147P |
| AQUIPTA TABLET 60MG | ABBVIE PTE. LTD. | AQUIPTA TABLET 60MG | Nov 29, 2024 | SIN17146P |
| AQUIPTA TABLET 10MG | ABBVIE PTE. LTD. | AQUIPTA TABLET 10MG | Nov 29, 2024 | SIN17145P |
| PREZEL 75 CAPSULE 75MG | GOLDPLUS UNIVERSAL PTE LTD | PREZEL 75 CAPSULE 75MG | Nov 28, 2024 | SIN17143P |
| PREZEL 150 CAPSULE 150MG | GOLDPLUS UNIVERSAL PTE LTD | PREZEL 150 CAPSULE 150MG | Nov 28, 2024 | SIN17144P |
| TALVEY SOLUTION FOR INJECTION 40MG/ML | JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD. | TALVEY SOLUTION FOR INJECTION 40MG/ML | Nov 15, 2024 | SIN17142P |
| TALVEY SOLUTION FOR INJECTION 3MG/1.5ML | JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD. | TALVEY SOLUTION FOR INJECTION 3MG/1.5ML | Nov 15, 2024 | SIN17141P |
| CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG | RANBAXY (MALAYSIA) SDN. BHD. | CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG | Nov 15, 2024 | SIN17139P |
| CILENTRA 10 ESCITALOPRAM OXALATE TABLET USP 10MG | RANBAXY (MALAYSIA) SDN. BHD. | CILENTRA 10 ESCITALOPRAM OXALATE TABLET USP 10MG | Nov 15, 2024 | SIN17140P |
| BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100 MG/ 1.0 ML | SANOFI-AVENTIS SINGAPORE PTE. LTD. | BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100 MG/ 1.0 ML | Nov 13, 2024 | SIN17138P |
| BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML | SANOFI-AVENTIS SINGAPORE PTE. LTD. | BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML | Nov 13, 2024 | SIN17137P |
